Fragile X Mental Retardation Protein (FMRP), Compositions, and Methods Related Thereto
The invention relates to fragile X mental retardation protein (FMRP), compositions, and methods related thereto. In certain embodiments, the invention relates to treating a neurological disorder by administering a P13K antagonist to a subject in need thereof. In other embodiments, the invention relates to methods of diagnosing neurological disorders.
Patents:WO 2,011,056,930
Inventor(s):
BASSELL GARY [US]; WARREN STEPHEN [US]; GROSS CHRISTINA [US]
Type of Offer:
Licensing
« More Diagnostic Patents